UNDERSTANDING AND MANAGING COMMON SIDE EFFECTS
Embarking on a weight loss journey often requires more than just diet and exercise, especially for individuals with obesity. While lifestyle changes are essential, some may also benefit from prescription medications like Saxenda to aid in their weight loss efforts. However, understanding the potential side effects of Saxenda is crucial for managing treatment effectively. In this guide, we’ll explore the most common side effects of Saxenda and practical tips for managing them.
WHAT IS SAXENDA
Saxenda, containing liraglutide as its active ingredient, is an FDA-approved injectable medication for weight management. It belongs to the GLP-1 receptor agonists class, designed to decrease appetite and slow stomach emptying, ultimately aiding in weight loss when combined with a healthy lifestyle.
COMMON SIDE EFFECTS OF SAXENDA
Saxenda’s mechanism of action can lead to gastrointestinal (GI) side effects, with nausea being the most prevalent, affecting nearly 40% of users. Other common side effects include diarrhea, constipation, vomiting, and skin reactions at the injection site. Additionally, heartburn, abdominal pain, headache, fatigue, dizziness, and low blood sugar may occur.
MANAGING SIDE EFFECTS
- Nausea – Eat smaller portions, avoid trigger foods, stay hydrated, consider ginger, and seek medical advice if severe.
- Diarrhea – Hydrate, avoid caffeine and dairy, consume high-fiber foods, consider over-the-counter medications, and consult a healthcare provider if symptoms persist.
- Constipation – Stay hydrated, increase fiber intake, consider supplements or laxatives, and consult a healthcare provider for persistent issues.
- Vomiting – Consume bland foods, stay hydrated, use anti-nausea medications if necessary, and seek medical attention for persistent vomiting.
- Injection Site Reactions – Practice proper injection techniques, rotate injection sites, and use cool compresses for mild irritation.
- Heartburn – Avoid trigger foods, consider over-the-counter medications, elevate head while sleeping, and consult a healthcare provider if symptoms worsen.
- Abdominal Pain – Eat smaller portions, manage underlying GI symptoms, and seek immediate medical attention for severe pain.
- Headache – Stay hydrated, consume regular meals, consider over-the-counter pain relievers, and contact a healthcare provider if headaches persist.
- Fatigue – Maintain adequate nutrition and hydration, prioritize quality sleep, and address persistent fatigue with a healthcare provider.
- Dizziness – Stay hydrated, manage blood sugar levels, and consult a healthcare provider for persistent dizziness or hypoglycemia.
LESS COMMON SIDE EFFECTS
Less common side effects include tachycardia (increased heart rate), facial swelling, depression, suicidal thoughts, yellowing of the skin or eyes, and kidney problems. Individuals experiencing these symptoms should seek immediate medical attention.
DURATION OF SIDE EFFECTS
Most Saxenda side effects are mild to moderate and typically resolve within days to weeks, especially after adjusting to the medication. Discontinuation due to side effects is rare, occurring in less than 10% of users.
TIPS FOR MINIMIZING SIDE EFFECTS
To minimize side effects, start with the lowest Saxenda dose, maintain consistency in dosing, rotate injection sites, stay hydrated, and communicate openly with healthcare providers regarding any concerns.
While Saxenda can be a valuable tool in weight management, understanding and managing its side effects are essential for treatment success. By implementing practical strategies and maintaining open communication with healthcare providers, individuals can navigate Saxenda treatment effectively while working towards their weight loss goals.
DISCLAIMER
For personalized medical advice and treatment, consult with your healthcare provider. The information provided here serves as educational content and should not replace professional medical guidance. While sourced from reputable sources, it is not a substitute for individualized healthcare recommendations.
SOURCES
- Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., Andreasen, A. H., Jensen, C. B., & DeFronzo, R. A. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA, 314(7), 687-699.
- Garvey, W. T., Birkenfeld, A. L., Dicker, D., Mingrone, G., Pedersen, S. D., Satylganova, A., Skovgaard, D., & Sugimoto, D. (2018). Efficacy and safety of liraglutide 3.0 mg for weight management in patients with obesity: The SCALE Obesity and Prediabetes Randomized Clinical Trial. Diabetes Care, 41(6), 1176-1185.
- Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Ortiz, R. V., & Jensen, C. B. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
- Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., Wilding, J. P. H., & Weyer, C. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial. JAMA, 325(14), 1403-1413.
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T., & Wadden, T. A. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.